BiotechTube
Home/Allogenica/Aymeric Bordet
AB

Aymeric Bordet

Chief Financial Officer

Allogenica

Therapeutic Areas

OncologyRare DiseasesAutoimmune Disorders

Allogenica Pipeline

DrugIndicationPhase
Lead Universal CAR-T CandidateCancer (unspecified)Pre-clinical

Leadership Team at Allogenica

IM
Inna Menkova, PhD
Chief Executive Officer and Co-founder
TA
Tobias Abel, PhD
Chief Scientific Officer
JL
Jean-Guillaume Lafay
Chairman of the Board of Directors and Co-founder
View full Allogenica profile